Fresenius Medical Care AG & Co. KGaA
FMS Healthcare Medical Care Facilities
Fresenius Medical Care AG & Co. KGaA’s revenue for fiscal 2025 (year ended December 2025) was $22.2 billion, up 6.13% from fiscal 2024.
- Revenue
- −0.49%
- EPS
- −10.6%
- Free cash flow
- −3.47%
- Total debt
- +8.09%
Quarter to September 2026, against a year earlier
Follow FMS
Alert me
Fresenius Medical Care AG & Co. KGaA (FMS) EBITDA
Fresenius Medical Care AG & Co. KGaA's EBITDA for fiscal 2025 was $3.8B, up 11.0% from $3.4B in fiscal 2024. Over the twelve months to 30 September 2026 it was $3.8B. Over the past ten years it has ranged from $3.0B (fiscal 2015) to $4.7B (fiscal 2020); the current reading is higher than 64% of that period. Fresenius Medical Care AG & Co. KGaA ranks 3rd of 48 Medical Care Facilities companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $3.8B | 10.99% |
| FY2024 | $3.4B | 0.41% |
| FY2023 | $3.4B | (4.29%) |
| FY2022 | $3.5B | (14.17%) |
| FY2021 | $4.1B | (11.98%) |
| FY2020 | $4.7B | 8.00% |
| FY2019 | $4.3B | (2.64%) |
| FY2018 | $4.4B | 26.91% |
| FY2017 | $3.5B | 2.58% |
| FY2016 | $3.4B | 12.14% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $930.8M | (3.07%) |
| Jun 2026 | $960.3M | 9.52% |
| Mar 2026 | $876.8M | (17.17%) |
| Dec 2025 | $1.1B | 5.81% |
| 43 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| THC Tenet Healthcare Corporation compare | $7.1B |
| FMS Fresenius Medical Care AG & Co. KGaA | $3.8B |
| DVA DaVita Inc. compare | $2.8B |
| UHS Universal Health Services, Inc. compare | $2.7B |
| EHC Encompass Health Corporation compare | $1.5B |
| ENSG The Ensign Group, Inc. compare | $630.9M |
| PACS PACS Group, Inc. compare | $500.6M |
| CON Concentra Group Holdings Parent, Inc. compare | $479.6M |
| CHE Chemed Corporation compare | $438.8M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on FMS
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement